Natera: The Clues In Q1 Earnings

Natera (NASDAQ: NTRA ) is a genetic testing company, with focuses on oncology, women's health, and organ health. Their signature product, Signatera, can help predict the efficacy of many forms of cancer treatment. Natera has alsoLike millions of other investors, I got Robinhood and started trading during the pandemic. Unlike most of those investors, I carefully studied hundreds of earnings reports for clues to future performance, and I was able to identify many future winners, such as OPRX, OTRK, FUBO, and ...